TG Therapeutics, Inc. Financial Ratios — TGTX Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	-143.58	-73.66	-92.85	-69.3	-113.87	-230.36	-381.16	-551.85	-100.14	-92.03	-151.36	11.57	12.21	102.75
Return on Assets (%)	-5.14	-98.73	-58.35	-82.73	-62.88	-93.02	-155.72	-191.7	-140.19	-70.85	-69.26	-78.09	4.84	5.15	54.5
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	12.06	12.13	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.69	10.25	- -
Gross Margin (%)	- -	100	100	100	100	100	100	100	100	100	88.19	90.48	93.95	88.3	83.66
EBITDA Margin (%)	- -	-135,395.65	-13,234.76	-36,564.38	-41,451.73	-51,911.84	-77,963.82	-114,590.13	-111,034.87	-179,750	-5,146.9	-7,820.5	9.01	12.83	20.05
Operating Margin (%)	- -	-135,396.89	-13,235.5	-36,566.96	-41,461.87	-51,953.29	-78,100	-114,736.84	-111,220.39	-179,996.05	-5,154.28	-7,838.99	8.83	12.74	20.01
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	103.5	22.34	28.33
Pretax Margin (%)	- -	-135,725.28	-13,438.82	-36,606.45	-41,310.04	-51,482.24	-77,944.74	-114,132.89	-113,730.92	-183,803.29	-5,204.08	-8,036.34	5.59	7.78	17.43
Profit Margin (%)	- -	-94,879.88	-13,438.82	-36,606.45	-41,310.04	-51,482.24	-77,944.74	-114,132.89	-113,730.92	-183,803.29	-5,204.08	-8,036.34	5.42	7.11	72.56
Net Income to Common Margin (%)	- -	-94,879.88	-13,438.82	-36,606.45	-41,310.04	-51,482.24	-77,944.74	-114,132.89	-113,730.92	-183,803.29	-5,204.08	-8,036.34	5.42	7.11	72.56
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.99	8.64	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	-143.58	-73.66	-92.85	-69.3	-113.87	-230.36	-381.16	-551.85	-100.14	-92.03	-151.36	11.57	12.21	102.75

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	4	3	1	- -	- -	- -	- -	- -	41	42	79	83	111	254	254
ST Debt	1	1	1	- -	- -	- -	- -	- -	2	24	2	2	1	1	1
LT Debt	3	2	- -	- -	- -	- -	- -	- -	39	18	77	81	109	253	253
Total Debt/EBITDA	-4.73	-0.12	-0.04	- -	- -	- -	- -	- -	-0.24	-0.15	-0.23	-0.38	5.26	6.01	2.05
Net Debt/EBITDA	6.32	0.52	1.97	1	0.87	0.32	0.48	0.24	0.5	1.92	0.67	0.14	0.34	1.53	1.35
Total Debt/EBIT	-4.73	-0.12	-0.04	- -	- -	- -	- -	- -	-0.24	-0.15	-0.23	-0.38	5.37	6.05	2.06
Net Debt/EBIT	6.32	0.52	1.97	0.99	0.87	0.32	0.48	0.24	0.49	1.91	0.67	0.14	0.35	1.54	1.35
EBITDA to Interest Expense	-124.27	-28.47	-21.16	-59.87	-64.93	- -	-140.24	-198.61	-31.92	-43.17	-61.06	-21.37	1.67	1.76	4.62
EBITDA-CapEx/Interest Expense	-124.27	-28.48	-21.17	-59.89	-64.98	- -	-140.24	-198.71	-31.95	-43.23	-61.13	-21.37	1.67	1.75	4.62
EBIT to Interest Expense	-124.27	-28.47	-21.17	-59.87	-64.95	- -	-140.49	-198.86	-31.98	-43.23	-61.15	-21.42	1.64	1.75	4.61
Interest Expense	- -	1	1	1	1	- -	1	1	5	6	6	10	13	24	27
Common Equity/Total Assets	66.2	70.45	83.25	92.34	89.51	65.47	68.79	28.75	23.69	83.01	62.47	30.27	48.7	38.49	60.95
Long-Term Debt/Equity (%)	34.19	15.94	0.16	- -	- -	- -	- -	- -	101.48	3.49	32.31	139.07	68.13	113.58	38.99
Long-Term Debt/Capital (%)	23.86	13.25	0.16	- -	- -	- -	- -	- -	49.34	3.23	24.24	57.52	40.31	53.05	28.02
Long-Term Debt/Total Assets (%)	22.66	11.23	0.13	- -	- -	- -	- -	- -	24.04	2.9	20.19	42.09	33.18	43.72	23.76
Total Debt/Equity (%)	43.3	20.3	1.85	0.34	0.21	0.19	0.19	0.28	105.67	8.08	33.33	141.77	69.03	114.1	39.15
Total Debt/Capital (%)	30.22	16.88	1.82	0.34	0.21	0.19	0.19	0.28	51.38	7.48	25	58.64	40.84	53.29	28.14
Total Debt/Total Assets (%)	28.7	14.3	1.54	0.32	0.19	0.13	0.13	0.08	25.03	6.71	20.82	42.91	33.62	43.92	23.86
Net Debt to Equity	-57.86	-85.52	-99.22	-69.21	-54	-69.6	-84.47	-174.28	-216.67	-100.81	-97.46	-53.2	4.48	29.02	25.69
Net Debt/Capital (%)	-137.33	-590.76	-12,765.48	-224.78	-117.39	-228.9	-543.98	234.62	251.87	-6,638.06	-1,334.97	-79.22	4.03	21.79	20.24
EBITDA	-1	-26	-20	-56	-63	-79	-119	-174	-169	-273	-344	-218	21	42	124
EBITDA-CapEx	-1	-26	-20	-56	-63	-79	-119	-174	-169	-274	-345	-218	21	42	123
Operating Income (Loss)	-1	-26	-20	-56	-63	-79	-119	-174	-169	-274	-345	-218	21	42	123

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	6.07	7.43	6.41	15.38	7.34	2.66	3.03	1.77	1.66	6.91	4.81	3.04	4.05	3.43	0.92
Current Ratio	6.12	8.34	6.7	16.64	8.25	3.01	3.34	2.03	1.77	6.99	5.06	3.16	5.92	6.25	4.1
Quick Ratio	6.07	7.43	6.41	15.4	7.35	2.66	3.03	1.78	1.66	6.91	4.84	3.04	5	4.85	2.91
CFO/Avg Current Liab	-0.04	-2.71	-2.52	-6.13	-5.71	-4.49	-4.18	-3.86	-2.15	-2.49	-3.87	-2.97	-0.59	-0.56	-0.2
Common Equity/Total Assets	66.2	70.45	83.25	92.34	89.51	65.47	68.79	28.75	23.69	83.01	62.47	30.27	48.7	38.49	60.95
Long-Term Debt/Equity (%)	34.19	15.94	0.16	- -	- -	- -	- -	- -	101.48	3.49	32.31	139.07	68.13	113.58	38.99
Long-Term Debt/Capital (%)	23.86	13.25	0.16	- -	- -	- -	- -	- -	49.34	3.23	24.24	57.52	40.31	53.05	28.02
Long-Term Debt/Total Assets (%)	22.66	11.23	0.13	- -	- -	- -	- -	- -	24.04	2.9	20.19	42.09	33.18	43.72	23.76
Total Debt/Equity (%)	43.3	20.3	1.85	0.34	0.21	0.19	0.19	0.28	105.67	8.08	33.33	141.77	69.03	114.1	39.15
Total Debt/Capital (%)	30.22	16.88	1.82	0.34	0.21	0.19	0.19	0.28	51.38	7.48	25	58.64	40.84	53.29	28.14
Total Debt/Total Assets (%)	28.7	14.3	1.54	0.32	0.19	0.13	0.13	0.08	25.03	6.71	20.82	42.91	33.62	43.92	23.86
CFO/Total Liabilities	-1.77	-79.52	-133.27	-527.61	-375.55	-325.62	-308.54	-216.39	-106.76	-201.81	-207.5	-130.51	-18.58	-11.4	-5.97
CFO/CapEx	- -	-3,708.34	-1,890.36	-1,887.99	-1,058.58	-179.03	-46,880	-1,432.5	-1,013.79	-600.86	-737.24	-12,583.57	- -	-900.38	-115.76
Altman's Z-Score	1.29	3.66	8.3	61.7	29.51	-1.82	3.46	-11.83	-3.16	38.64	4.41	-6.4	4.45	6.01	6.77

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.63	4.01	9.15	3.65	2.83
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	37.9	91.02	39.91	100	128.76
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.71	0.51	0.85
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	514.31	712.63	427.73
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	37.9	91.02	554.21	812.63	556.49
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	37.9	91.02	-474.4	-612.63	-298.97
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	40	110	126
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	40	110	126

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	6	94	134	712	645	264	600	344	1,214	7,313	2,722	1,732	2,586	4,691	4,630
- Cash & Cash Equivalents	10	16	40	56	55	25	57	42	113	553	299	102	93	180	79
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	4	3	1	- -	- -	- -	- -	- -	41	42	79	83	111	254	254
Enterprise Value	- -	81	94	633	568	219	515	275	1,115	6,749	2,486	1,653	2,480	4,633	4,741
Total Capital	14	19	41	80	102	36	67	24	79	561	316	142	271	476	902
Total Debt/Capital (%)	30.22	16.88	1.82	0.34	0.21	0.19	0.19	0.28	51.38	7.48	25	58.64	40.84	53.29	28.14
Total Debt / EV	26.88	0.04	0.01	- -	- -	- -	- -	- -	0.04	0.01	0.03	0.05	0.04	0.05	0.05
EV/Sales	- -	4,236.05	616.92	4,155.62	3,726.49	1,442.15	3,389.23	1,809.44	7,332.44	44,403.48	371.66	593.58	10.61	14.08	7.69
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	117.76	109.77	38.37
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	120.18	110.51	38.45
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	54.8
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	54.67
Diluted Market Cap	2	48	99	540	545	228	509	309	981	6,000	2,512	1,602	2,537	4,826	4,812
Diluted Enterprise Value	-3	34	59	484	490	203	452	268	909	5,488	2,292	1,583	2,554	4,900	4,986
EV per Share	0.03	3.12	2.74	14.09	10.51	3.86	7.04	3.28	10.19	48.01	17.35	11.29	16.38	29.73	30.53
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7	3	234	329	616
TTM EBITDA	-1	-26	-20	-56	-63	-79	-119	-174	-169	-273	-344	-218	21	42	124
TTM Operating Income	-1	-26	-20	-56	-63	-79	-119	-174	-169	-274	-345	-218	21	42	123
TTM Cash Flow to Firm	- -	-4	-10	-34	-44	-62	-93	-128	-128	-208	-290	-166	-19	-19	87
TTM Free Cash Flow to Firm	- -	-4	-10	-34	-44	-61	-93	-128	-127	-208	-290	-166	-19	-19	87

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-25.14	-9.2	-9.23	-15.4	-12.2	-3.72	-5.43	-2.4	-7.39	-28.02	-8.51	-9.09	-80.75	-119.25	-195.93
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	120.18	110.51	38.45
Enterprise Value	- -	81	94	633	568	219	515	275	1,115	6,749	2,486	1,653	2,480	4,633	4,741
Low Price	0.96	1.13	2.97	3.83	9.54	4.5	4.1	3.32	3.87	6.34	12.62	3.48	6.46	12.84	25.28
EV/Sales	- -	4,236.05	616.92	4,155.62	3,726.49	1,442.15	3,389.23	1,809.44	7,332.44	44,403.48	371.66	593.58	10.61	14.08	7.69
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	117.76	109.77	38.37
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	191.33	187.06	9.62
Price/Earnings Average	-60.92	-3.75	-6.34	-5.31	-10.6	-4.56	-5.05	-4.67	-3.53	-8.86	-13.64	-4.78	186.12	128.52	11.01
Price/Earnings High	-508.04	-36.74	-9.62	-11.53	-14.5	-7.37	-8.04	-7.55	-5.84	-23.16	-21.55	-12.52	399.58	228.95	15
Price/Earnings Low	-2.16	-0.82	-3.69	-2.34	-6.92	-2.82	-2.15	-1.44	-1.98	-2.62	-4.79	-2.11	72.37	79.8	8.16
Price/Book Value	0.59	6.04	3.34	8.89	6.35	7.36	8.95	14.31	31.44	14.08	11.48	29.56	16.11	21.09	7.14
Price/Book Value Average	14.19	8.57	4.37	4.88	7.78	11.53	10.52	37.43	19.54	5.81	21.68	19.73	15.67	14.49	8.17
Price/Book Value High	118.32	84.07	6.64	10.59	10.64	18.62	16.76	60.54	32.35	15.19	34.27	51.7	33.65	25.82	11.14
Price/Book Value Low	0.5	1.88	2.54	2.15	5.08	7.12	4.48	11.58	10.96	1.72	7.62	8.7	6.09	9	6.06
Price/Tangible Book Value	1.16	7.86	3.41	8.97	6.4	7.53	9.06	14.8	32.11	14.1	11.52	29.97	16.19	21.09	7.14
Price/Tangible Book Value Average	27.74	11.15	4.46	4.93	7.84	11.79	10.65	38.72	19.96	5.82	21.76	20	15.75	14.49	8.17
Price/Tangible Book Value High	231.34	109.37	6.77	10.7	10.73	19.04	16.96	62.62	33.03	15.21	34.39	52.41	33.82	25.82	11.14
Price/Tangible Book Value Low	0.98	2.44	2.59	2.17	5.12	7.29	4.53	11.98	11.19	1.72	7.65	8.82	6.13	9	6.06
Price/Sales	- -	2,505.99	650.44	3,541.46	3,573.69	1,500.28	3,348.49	2,035.62	6,453.25	39,471.44	375.58	575.19	10.38	13.29	6.98
Price/Sales Average	- -	3,554.9	851.76	1,943.61	4,378.12	2,349.57	3,934.22	5,326.17	4,011.37	16,293.4	709.61	383.88	10.09	9.13	7.99
Price/Sales High	- -	34,856.66	1,292.54	4,221.14	5,991.09	3,794.25	6,268.21	8,614.14	6,639.29	42,574.83	1,121.59	1,005.98	21.67	16.27	10.88
Price/Sales Low	- -	777.96	495.33	856.3	2,857.75	1,451.88	1,674.24	1,648.35	2,249.92	4,810.63	249.46	169.2	3.92	5.67	5.92
Price/Cash Flow	-25.14	-9.2	-9.23	-15.39	-12.19	-3.7	-5.43	-2.4	-7.39	-27.97	-8.5	-9.09	-77.18	-107.96	-173.67
Price/Cash Flow Average	-600.28	-13.05	-12.09	-8.45	-14.93	-5.8	-6.38	-6.28	-4.59	-11.55	-16.06	-6.07	-75.08	-74.17	-198.67
Price/Cash Flow High	-5,005.89	-127.98	-18.34	-18.35	-20.43	-9.36	-10.16	-10.16	-7.6	-30.17	-25.38	-15.9	-161.19	-132.13	-270.78
Price/Cash Flow Low	-21.28	-2.86	-7.03	-3.72	-9.74	-3.58	-2.71	-1.94	-2.58	-3.41	-5.64	-2.67	-29.19	-46.05	-147.28
Price/Free Cash Flow Average	-600.28	-13.06	-12.09	-8.45	-14.94	-5.83	-6.38	-6.28	-4.6	-11.56	-16.08	-6.07	-78.55	-81.93	-224.14
Price/Free Cash Flow High	-5,005.89	-128.01	-18.35	-18.36	-20.45	-9.42	-10.16	-10.16	-7.61	-30.22	-25.41	-15.9	-168.63	-145.95	-305.5
Price/Free Cash Flow Low	-21.28	-2.86	-7.03	-3.72	-9.75	-3.6	-2.71	-1.94	-2.58	-3.41	-5.65	-2.68	-30.54	-50.87	-166.16
EV/Sales Average	- -	6,301.33	888.6	2,199.57	4,824.55	2,556.05	4,263.64	5,643.68	4,492.73	16,494.58	735.92	408.08	10.84	10.02	8.88
EV/Sales High	- -	67,933.9	1,483.4	5,203.37	6,734.61	4,228.68	7,013.92	9,297.78	7,745.6	48,528.11	1,182.27	1,080.6	23.19	17.67	12
EV/Sales Low	- -	833.59	407.61	765.55	3,024.15	1,516.73	1,600.56	1,556.31	2,312.39	2,498.62	237.4	176.01	4.26	6.31	6.65
EV/EBITDA Average	-148.52	-4.65	-6.71	-6.02	-11.64	-4.92	-5.47	-4.93	-4.05	-9.18	-14.3	-5.22	120.33	78.1	44.27
EV/EBITDA High	-1,284.83	-50.17	-11.21	-14.23	-16.25	-8.15	-9	-8.11	-6.98	-27	-22.97	-13.82	257.37	137.76	59.83
EV/EBITDA Low	0.82	-0.62	-3.08	-2.09	-7.3	-2.92	-2.05	-1.36	-2.08	-1.39	-4.61	-2.25	47.31	49.15	33.19
EV/EBIT Average	-148.52	-4.65	-6.71	-6.02	-11.64	-4.92	-5.46	-4.92	-4.04	-9.16	-14.28	-5.21	122.8	78.62	44.36
EV/EBIT High	-1,284.83	-50.17	-11.21	-14.23	-16.24	-8.14	-8.98	-8.1	-6.96	-26.96	-22.94	-13.78	262.65	138.68	59.95
EV/EBIT Low	0.82	-0.62	-3.08	-2.09	-7.29	-2.92	-2.05	-1.36	-2.08	-1.39	-4.61	-2.25	48.28	49.48	33.25
Last Price	1.13	3.64	3.9	15.84	11.93	4.65	8.2	4.1	11.1	52.02	19	11.83	17.08	30.1	29.81
High Price	225	50.63	7.75	18.88	20	11.76	15.35	17.35	11.42	56.11	56.74	20.69	35.67	36.84	46.48
Enterprise Value Average	131	120	135	335	735	389	648	858	683	2,507	4,923	1,136	2,534	3,297	5,471
Enterprise Value High	1,133	1,294	226	793	1,026	643	1,066	1,413	1,177	7,376	7,908	3,009	5,419	5,815	7,393
Enterprise Value Low	-1	16	62	117	461	231	243	237	351	380	1,588	490	996	2,075	4,101

Shares Outstanding	5	26	34	45	54	57	73	84	109	141	143	146	151	156	155
Diluted Weighted Avg Shares	2	13	25	34	46	49	62	75	88	115	132	135	149	160	161
Basic Weighted Avg Shares	2	13	25	34	46	49	62	75	88	115	132	135	142	145	144
Revenue per Share	- -	- -	0.01	- -	- -	- -	- -	- -	- -	- -	0.05	0.02	1.65	2.26	4.27
EBITDA per Share	-0.46	-1.97	-0.79	-1.64	-1.38	-1.61	-1.91	-2.31	-1.91	-2.37	-2.6	-1.61	0.15	0.29	0.86
Operating Income per Share	-0.46	-1.97	-0.79	-1.64	-1.38	-1.61	-1.91	-2.31	-1.91	-2.37	-2.61	-1.61	0.15	0.29	0.85
Basic EPS, GAAP	-0.44	-1.38	-0.81	-1.64	-1.38	-1.6	-1.91	-2.3	-1.96	-2.42	-2.63	-1.65	0.09	0.16	3.1
Basic EPS from Cont Ops	-0.46	-2	-0.81	-1.64	-1.38	-1.6	-1.91	-2.3	-1.96	-2.42	-2.63	-1.65	0.09	0.16	3.1
Diluted EPS, GAAP	-0.44	-1.38	-0.81	-1.64	-1.38	-1.6	-1.91	-2.3	-1.96	-2.42	-2.63	-1.65	0.09	0.15	2.77
Diluted EPS from Cont Ops	-0.46	-2	-0.81	-1.64	-1.38	-1.6	-1.91	-2.3	-1.96	-2.42	-2.63	-1.65	0.09	0.15	2.77
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.04	-0.4	-0.42	-1.03	-0.98	-1.26	-1.51	-1.71	-1.5	-1.86	-2.24	-1.3	-0.22	-0.28	-0.17
Free Cash Flow per Basic Share	-0.04	-0.4	-0.42	-1.03	-0.98	-1.26	-1.51	-1.71	-1.5	-1.86	-2.24	-1.3	-0.22	-0.28	-0.17
Cash & Equivalents per Share	1.93	0.64	1.18	1.75	1.43	0.79	1.16	0.82	1.28	4.31	2.2	1.1	1.44	2	0.91
Book Value per Share	1.9	0.6	1.17	1.78	1.88	0.63	0.92	0.29	0.35	3.69	1.66	0.4	1.06	1.43	4.17
Tangible Book Value per Share	0.97	0.46	1.14	1.76	1.86	0.62	0.91	0.28	0.35	3.69	1.65	0.39	1.05	1.43	4.17

TG Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)